Comparing the Efficacy of Postoperative Pain Control Between Intravenous Parecoxib and Oral Diclofenac in ACL Reconstruction
© The Author(s) 2021..
BACKGROUND: A nonsteroidal anti-inflammatory drug such as oral diclofenac is normally used to relieve postoperative pain after anterior cruciate ligament reconstruction (ACLR), but most patients continue to have moderate-to-severe pain that disturbs their rehabilitation. Some orthopaedists prefer to use intravenous (IV) parecoxib for postoperative pain control.
PURPOSE: To compare the efficacy of IV parecoxib and oral diclofenac for postoperative pain control in ACLR.
STUDY DESIGN: Cohort study; Level of evidence, 3.
METHODS: We retrospectively collected and analyzed postoperative pain in patients who underwent both single- and double-bundle ACLR; pain was reported on a 10-point visual analog scale (VAS; 10 = worst pain). After the operation, each patient was given either IV parecoxib twice a day or oral diclofenac 3 times a day, and all patients received paracetamol 6 times per day for 24 hours postoperatively. If the patient complained of moderate or severe pain (VAS >3) after surgery, 3 mg of morphine would be given intravenously every 3 hours and 1 mg of morphine as a rescue analgesic every 1 hour for 24 hours postoperatively. Postoperative VAS and morphine consumption were recorded every 4 hours for 24 hours. Data were analyzed using paired t test, analysis of variance, and chi-square test.
RESULTS: Overall, 161 patients were included in this study, of whom 47 received IV parecoxib and 114 received oral diclofenac. The mean VAS scores at 4 and 8 hours postoperatively were 3.5 and 3.4, respectively, in the parecoxib group, and 4.4 and 4.7, respectively, in the diclofenac group. The parecoxib group had significantly lower mean VAS than the diclofenac group at 4 hours (P = .047) and 8 hours (P = .005), and the mean cumulative morphine consumption in the parecoxib group was significantly lower than in the diclofenac group at all time points (P < .05) except 4 hours postoperatively.
CONCLUSION: This study found that IV parecoxib was more effective than oral diclofenac in controlling postoperative pain and resulted in lower postoperative morphine consumption within the first 24 hours after ACLR.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
|---|---|
| Enthalten in: |
Orthopaedic journal of sports medicine - 9(2021), 10 vom: 04. Okt., Seite 23259671211041660 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Chuaychoosakoon, Chaiwat [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Anterior cruciate ligament |
|---|
| Anmerkungen: |
Date Revised 27.04.2022 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1177/23259671211041660 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM332329763 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM332329763 | ||
| 003 | DE-627 | ||
| 005 | 20231225215346.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1177/23259671211041660 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1107.xml |
| 035 | |a (DE-627)NLM332329763 | ||
| 035 | |a (NLM)34692879 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Chuaychoosakoon, Chaiwat |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Comparing the Efficacy of Postoperative Pain Control Between Intravenous Parecoxib and Oral Diclofenac in ACL Reconstruction |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 27.04.2022 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © The Author(s) 2021. | ||
| 520 | |a BACKGROUND: A nonsteroidal anti-inflammatory drug such as oral diclofenac is normally used to relieve postoperative pain after anterior cruciate ligament reconstruction (ACLR), but most patients continue to have moderate-to-severe pain that disturbs their rehabilitation. Some orthopaedists prefer to use intravenous (IV) parecoxib for postoperative pain control | ||
| 520 | |a PURPOSE: To compare the efficacy of IV parecoxib and oral diclofenac for postoperative pain control in ACLR | ||
| 520 | |a STUDY DESIGN: Cohort study; Level of evidence, 3 | ||
| 520 | |a METHODS: We retrospectively collected and analyzed postoperative pain in patients who underwent both single- and double-bundle ACLR; pain was reported on a 10-point visual analog scale (VAS; 10 = worst pain). After the operation, each patient was given either IV parecoxib twice a day or oral diclofenac 3 times a day, and all patients received paracetamol 6 times per day for 24 hours postoperatively. If the patient complained of moderate or severe pain (VAS >3) after surgery, 3 mg of morphine would be given intravenously every 3 hours and 1 mg of morphine as a rescue analgesic every 1 hour for 24 hours postoperatively. Postoperative VAS and morphine consumption were recorded every 4 hours for 24 hours. Data were analyzed using paired t test, analysis of variance, and chi-square test | ||
| 520 | |a RESULTS: Overall, 161 patients were included in this study, of whom 47 received IV parecoxib and 114 received oral diclofenac. The mean VAS scores at 4 and 8 hours postoperatively were 3.5 and 3.4, respectively, in the parecoxib group, and 4.4 and 4.7, respectively, in the diclofenac group. The parecoxib group had significantly lower mean VAS than the diclofenac group at 4 hours (P = .047) and 8 hours (P = .005), and the mean cumulative morphine consumption in the parecoxib group was significantly lower than in the diclofenac group at all time points (P < .05) except 4 hours postoperatively | ||
| 520 | |a CONCLUSION: This study found that IV parecoxib was more effective than oral diclofenac in controlling postoperative pain and resulted in lower postoperative morphine consumption within the first 24 hours after ACLR | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a anterior cruciate ligament | |
| 650 | 4 | |a arthroscopic surgery | |
| 650 | 4 | |a postoperative pain | |
| 650 | 4 | |a reconstruction | |
| 700 | 1 | |a Parinyakhup, Wachiraphan |e verfasserin |4 aut | |
| 700 | 1 | |a Wiwatboworn, Arnan |e verfasserin |4 aut | |
| 700 | 1 | |a Purngpiputtrakul, Peeranut |e verfasserin |4 aut | |
| 700 | 1 | |a Wanasitchaiwat, Pawin |e verfasserin |4 aut | |
| 700 | 1 | |a Boonriong, Tanarat |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Orthopaedic journal of sports medicine |d 2013 |g 9(2021), 10 vom: 04. Okt., Seite 23259671211041660 |w (DE-627)NLM243038488 |x 2325-9671 |7 nnns |
| 773 | 1 | 8 | |g volume:9 |g year:2021 |g number:10 |g day:04 |g month:10 |g pages:23259671211041660 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1177/23259671211041660 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 9 |j 2021 |e 10 |b 04 |c 10 |h 23259671211041660 | ||